"{\n \"business_address\": \"LILLY CORPORATE CTR, DROP CODE 1112, INDIANAPOLIS, IN 46285\", \n \"business_phone_no\": \"3172762000\", \n \"ceo\": \"David A. Ricks\", \n \"cik\": \"0000059478\", \n \"company_url\": \"www.lilly.com\", \n \"employees\": 41975, \n \"entity_legal_form\": null, \n \"entity_status\": null, \n \"hq_address1\": null, \n \"hq_address2\": null, \n \"hq_address_city\": null, \n \"hq_address_postal_code\": null, \n \"hq_country\": \"United States of America\", \n \"hq_state\": \"Indiana\", \n \"inc_country\": \"United States of America\", \n \"inc_state\": \"Indiana\", \n \"industry_category\": \"Drugs\", \n \"industry_group\": \"Drug Manufacturers - Major\", \n \"latest_filing_date\": \"2017-07-28\", \n \"legal_name\": \"LILLY ELI & CO\", \n \"lei\": \"FRDRIPF3EKNDJ2CQJL29\", \n \"long_description\": \"Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine headaches. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, and heartworm diseases, as well as controls intestinal parasite infections. Additionally, the company offers vaccinev to prevent Lyme disease, bronchial infections, rabies, and various infectious diseases in dogs, cats, and horses. It has collaboration agreements with Daiichi Sankyo Co., Ltd., Incyte Corporation, Pfizer Inc., AstraZeneca, and William Sansum Diabetes Center. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.\", \n \"mailing_address\": \"LILLY CORPORATE CENTER, DROP CODE 1112, INDIANAPOLIS, IN 46285\", \n \"name\": \"Eli Lilly and Co\", \n \"sector\": \"Healthcare\", \n \"securities\": [\n  {\n   \"composite_figi\": \"BBG000BNBDC2\", \n   \"composite_figi_ticker\": \"LLY:US\", \n   \"currency\": \"USD\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XNYS\", \n   \"figi\": \"BBG000BNBDC2\", \n   \"figi_exch_cntry\": \"US\", \n   \"figi_ticker\": \"LLY:US\", \n   \"figi_uniqueid\": \"EQ0010089400001000\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XNYS\", \n   \"primary_listing\": true, \n   \"security_name\": \"ELI LILLY & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"NYSE\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XDUS\", \n   \"figi\": \"BBG000F48N32\", \n   \"figi_exch_cntry\": \"GD\", \n   \"figi_ticker\": \"LLY:GD\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XDUS\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"DUS\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XFRA\", \n   \"figi\": \"BBG000F48MY0\", \n   \"figi_exch_cntry\": \"GF\", \n   \"figi_ticker\": \"LLY:GF\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XFRA\", \n   \"primary_listing\": false, \n   \"security_name\": \"ELI LILLY & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"FRA\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XMUN\", \n   \"figi\": \"BBG000F48PK8\", \n   \"figi_exch_cntry\": \"GM\", \n   \"figi_ticker\": \"LLY:GM\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XMUN\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"MUN\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSTU\", \n   \"figi\": \"BBG000F48NR6\", \n   \"figi_exch_cntry\": \"GS\", \n   \"figi_ticker\": \"LLY:GS\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XSTU\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"STU\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000C1V188\", \n   \"composite_figi_ticker\": \"LLY:SW\", \n   \"currency\": \"CHF\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSWX\", \n   \"figi\": \"BBG000C1V259\", \n   \"figi_exch_cntry\": \"SE\", \n   \"figi_ticker\": \"LLY:SE\", \n   \"figi_uniqueid\": \"EQ0010089400022000\", \n   \"last_crsp_adj_date\": \"2017-08-10\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XSWX\", \n   \"primary_listing\": false, \n   \"security_name\": \"ELI LILLY & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"SIX\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XHAN\", \n   \"figi\": \"BBG000F48MH9\", \n   \"figi_exch_cntry\": \"GR\", \n   \"figi_ticker\": \"LLY:GR\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XHAN\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"HAN\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XHAM\", \n   \"figi\": \"BBG000F48RQ8\", \n   \"figi_exch_cntry\": \"GH\", \n   \"figi_ticker\": \"LLY:GH\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XHAM\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"HAM\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XETR\", \n   \"figi\": \"BBG000F48RV2\", \n   \"figi_exch_cntry\": \"GQ\", \n   \"figi_ticker\": \"LLY:GQ\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XETR\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"XETRA\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": null, \n   \"composite_figi_ticker\": null, \n   \"currency\": \"SEK\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSTO\", \n   \"figi\": null, \n   \"figi_exch_cntry\": null, \n   \"figi_ticker\": null, \n   \"figi_uniqueid\": null, \n   \"last_crsp_adj_date\": null, \n   \"market_sector\": null, \n   \"mic\": \"XSTO\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Ordinary Shares\", \n   \"share_class_figi\": null, \n   \"stock_exchange\": \"STO\", \n   \"ticker\": \"E-US5324571083\"\n  }, \n  {\n   \"composite_figi\": \"BBG000NSFS40\", \n   \"composite_figi_ticker\": \"LLYCHF:XL\", \n   \"currency\": \"CHF\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XLON\", \n   \"figi\": \"BBG000NSH2L6\", \n   \"figi_exch_cntry\": \"XL\", \n   \"figi_ticker\": \"LLYCHF:XL\", \n   \"figi_uniqueid\": \"EQ0000000005249805\", \n   \"last_crsp_adj_date\": \"2015-11-09\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XLON\", \n   \"primary_listing\": false, \n   \"security_name\": \"ELI LILLY & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"LSE\", \n   \"ticker\": \"0Q1G\"\n  }, \n  {\n   \"composite_figi\": \"BBG004CH2YY6\", \n   \"composite_figi_ticker\": \"LLY:FP\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XPAR\", \n   \"figi\": \"BBG004CH2Z00\", \n   \"figi_exch_cntry\": \"FP\", \n   \"figi_ticker\": \"LLY:FP\", \n   \"figi_uniqueid\": \"EQ0000000029397273\", \n   \"last_crsp_adj_date\": \"2016-02-10\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XPAR\", \n   \"primary_listing\": false, \n   \"security_name\": \"ELI LILLY & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"PAR\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000CC90T8\", \n   \"composite_figi_ticker\": \"LLY*:MM\", \n   \"currency\": \"MXN\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XMEX\", \n   \"figi\": \"BBG000CC9143\", \n   \"figi_exch_cntry\": \"MM\", \n   \"figi_ticker\": \"LLY*:MM\", \n   \"figi_uniqueid\": \"EQ0000000001393314\", \n   \"last_crsp_adj_date\": \"2017-02-13\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XMEX\", \n   \"primary_listing\": false, \n   \"security_name\": \"ELI LILLY & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"MEX\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000F48MH9\", \n   \"composite_figi_ticker\": \"LLY:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XBER\", \n   \"figi\": \"BBG000F48Q26\", \n   \"figi_exch_cntry\": \"GB\", \n   \"figi_ticker\": \"LLY:GB\", \n   \"figi_uniqueid\": \"EQ0010089400001003\", \n   \"last_crsp_adj_date\": \"2017-08-11\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XBER\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"BER\", \n   \"ticker\": \"LLY\"\n  }, \n  {\n   \"composite_figi\": \"BBG000C1V188\", \n   \"composite_figi_ticker\": \"LLY:SW\", \n   \"currency\": \"CHF\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XBRN\", \n   \"figi\": \"BBG006M6Y8R4\", \n   \"figi_exch_cntry\": \"BW\", \n   \"figi_ticker\": \"LLY:BW\", \n   \"figi_uniqueid\": \"EQ0010089400022000\", \n   \"last_crsp_adj_date\": null, \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XBRN\", \n   \"primary_listing\": false, \n   \"security_name\": \"LILLY(ELI) & CO\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5STL8\", \n   \"stock_exchange\": \"BRN\", \n   \"ticker\": \"US5324571083\"\n  }\n ], \n \"short_description\": \"Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. It operates through the Human Pharmaceutical Products and Animal Health segments. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing, and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular, and other. The Animal health segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The Other Pharmaceuticals products include anti-infectives, primarily Vancocin and Ceclor, and other miscellaneous pharmaceutical products and services. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.\", \n \"sic\": 2834, \n \"standardized_active\": true, \n \"stock_exchange\": \"NYSE\", \n \"template\": \"industrial\", \n \"ticker\": \"LLY\"\n}"